trans[4-(1-propargyl)cyclohexylmethyl] benzyl carbonate | 506437-74-7

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: trans[4-(1-propargyl)cyclohexylmethyl] benzyl carbonate
• CAS: 506437-74-7
• 化学式: C₁₈H₂₂O₃
• 分子量: 286.371
• InChiKey: QOWQQEBITARLMZ-JCNLHEQBSA-N

物化性质

• 沸点：
  389.6±25.0 °C(Predicted)
• 密度：
  1.064±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.17
• 重原子数：
  21.0
• 可旋转键数：
  5.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  35.53
• 氢给体数：
  0.0
• 氢受体数：
  3.0

文献信息

• 2-PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY AND COMPOSITIONS THEREOF
  申请人：Linden M. Joel

  公开号：US20070232559A1

  公开（公告）日：2007-10-04

  The invention provides compounds having the following general formula (I): wherein X, R 1 , R 2 , R 7 and Z are as described here.

  该发明提供具有以下一般式（I）的化合物：其中X，R1，R2，R7和Z如此描述。
• 2-PROPYNYL ADENOSINE ANALOGS WITH MODIFIED 5'-RIBOSE GROUPS HAVING A2A AGONIST ACTIVITY
  申请人：Rieger Jayson M.

  公开号：US20090253647A1

  公开（公告）日：2009-10-08

  The invention provides compounds having the following general formula (I): wherein X, R 1 , R 2 , R 7 and Z are as described herein.

  本发明提供具有以下一般式（I）的化合物：其中X，R1，R2，R7和Z如本文所述。
• 2-POLYCYCLIC PROPYNYL ADENOSINE ANALOGS HAVING A2A AGONIST ACTIVITY
  申请人：Rieger Jayson M.

  公开号：US20090298788A1

  公开（公告）日：2009-12-03

  The invention provides compounds having the following general formula (I): wherein X, R 1 , R 2 , R 7 and Z are as described herein.

  本发明提供具有以下一般式(I)的化合物：其中X、R1、R2、R7和Z如本文所述。
• ADJUNCTIVE TREATMENT OF BIOLOGICAL DISEASES
  申请人：Linden Joel M.

  公开号：US20090170803A1

  公开（公告）日：2009-07-02

  The present invention provides a therapeutic method for treating biological diseases that includes the administration of an effective amount of a suitable antibiotic agent, antifungal agent or antiviral agent in conjunction with an A 2A adenosine receptor agonist. If no anti-pathogenic agent is known the A 2A agonist can be used alone to reduce inflammation, as may occur during infection with antibiotic resistant bacteria, or certain viruses such as those that cause SARS or Ebola. Optionally, the method includes administration of a type IV PDE inhibitor.

  本发明提供了一种治疗生物疾病的治疗方法，包括在适当的抗生素、抗真菌或抗病毒药物的有效剂量的同时使用A2A腺苷受体激动剂。如果不知道抗病原体药物，A2A激动剂可以单独使用来减轻炎症，例如在感染抗生素耐药菌或某些病毒（如SARS或埃博拉病毒）时可能发生的情况。可选地，该方法包括给予第四型PDE抑制剂。
• US7214665B2
  申请人：——

  公开号：US7214665B2

  公开（公告）日：2007-05-08